{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:48:36Z","timestamp":1789886916525,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ancard.2011.07.008","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:49:01Z","timestamp":1314838141000},"page":"111-117","source":"Crossref","is-referenced-by-count":3,"title":["La polyarthrite rhumato\u00efde\u00a0: une maladie cardiovasculaire\u00a0?"],"prefix":"10.1016","volume":"61","author":[{"given":"C.I.","family":"Da\u00efen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2011.07.008_bib0005","first-page":"673","article-title":"Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature","volume":"26","author":"L\u00e9vy","year":"2008","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0010","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/art.21932","article-title":"Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis","volume":"54","author":"Van Doornum","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"Douglas","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ancard.2011.07.008_bib0020","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/ar1775","article-title":"Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study","volume":"7","author":"Warrington","year":"2005","journal-title":"Arthritis research."},{"key":"10.1016\/j.ancard.2011.07.008_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.ancard.2011.07.008_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127\u00a0cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01450894","article-title":"Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease","volume":"17","author":"Wis\u0142owska","year":"1998","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0045","first-page":"493","article-title":"Dilatation of the mitral and aortic valves. Current trends","volume":"38","author":"Grollier","year":"1989","journal-title":"Ann Cardiol Angeiol (Paris)."},{"key":"10.1016\/j.ancard.2011.07.008_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.eurheartj.a060892","article-title":"Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease","volume":"16","author":"Corrao","year":"1995","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ancard.2011.07.008_bib0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10067-003-0842-y","article-title":"The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis","volume":"23","author":"Wiland","year":"2004","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0060","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rinc\u00f3n","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.22912","article-title":"Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample","volume":"57","author":"De Pablo","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0070","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.21397","article-title":"Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis","volume":"52","author":"del Rinc\u00f3n","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ancard.2011.07.008_bib0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/sarh.2001.27719","article-title":"Cigarette smoking and rheumatoid arthritis","volume":"31","author":"Albano","year":"2001","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0090","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","article-title":"Cardiovascular risk factors in women with and without rheumatoid arthritis","volume":"50","author":"Solomon","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002281-200203000-00003","article-title":"Influence of cigarette smoking on disease outcome in rheumatoid arthritis","volume":"14","author":"Harrison","year":"2002","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2003.09.037","article-title":"Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction","volume":"93","author":"Fischer","year":"2004","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0105","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2\u00a0to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00041433-199410000-00005","article-title":"Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk","volume":"5","author":"Krauss","year":"1994","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0115","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.0000168055.89955.db","article-title":"Arterial stiffness in chronic inflammatory diseases","volume":"46","author":"Roman","year":"2005","journal-title":"Hypertension."},{"key":"10.1016\/j.ancard.2011.07.008_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.HYP.0000185463.27209.b0","article-title":"Arterial stiffness is related to systemic inflammation in essential hypertension","volume":"46","author":"Mahmud","year":"2005","journal-title":"Hypertension."},{"key":"10.1016\/j.ancard.2011.07.008_bib0140","first-page":"398","article-title":"Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity","volume":"35","author":"Kerekes","year":"2008","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","article-title":"Oxidation in rheumatoid arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ancard.2011.07.008_bib0150","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2009.111211","article-title":"Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint","volume":"69","author":"Biniecka","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ancard.2011.07.008_bib0155","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.10419","article-title":"Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients","volume":"46","author":"Goodson","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0160","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3132\/dvdr.2007.031","article-title":"Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis","volume":"4","author":"La Montagna","year":"2007","journal-title":"Diab Vasc Dis Res."},{"key":"10.1016\/j.ancard.2011.07.008_bib0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.0954-6820.1983.tb03750.x","article-title":"Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids","volume":"213","author":"H\u00e4llgren","year":"1983","journal-title":"Acta Med Scand."},{"key":"10.1016\/j.ancard.2011.07.008_bib0175","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.22053","article-title":"Insulin resistance and impaired beta cell function in rheumatoid arthritis","volume":"54","author":"Dessein","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0180","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.10388","article-title":"High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment","volume":"46","author":"Ziolkowska","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0185","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.ancard.2011.07.008_bib0190","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2337\/diacare.28.9.2176","article-title":"Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2\u00a0diabetic patients","volume":"28","author":"Avignon","year":"2005","journal-title":"Diabetes Care."},{"key":"10.1016\/j.ancard.2011.07.008_bib0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1681\/ASN.2005030260","article-title":"Plasma osteoprotegerin is associated with mortality in hemodialysis patients","volume":"17","author":"Morena","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0200","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.106.652842","article-title":"Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study","volume":"115","author":"Levy","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ancard.2011.07.008_bib0205","first-page":"1619","article-title":"Cardiovascular risk factors in Chilean patients with rheumatoid arthritis","volume":"29","author":"Cisternas","year":"2002","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0210","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.ancard.2011.07.008_bib0215","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.106.636746","article-title":"Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation."},{"issue":"Suppl. 1","key":"10.1016\/j.ancard.2011.07.008_bib0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0755-4982(06)74941-7","article-title":"Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?","volume":"35","author":"Flipo","year":"2006","journal-title":"Presse Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0225","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0230","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.ancard.2011.07.008_bib0235","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ancard.2011.07.008_bib0240","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(00)02222-4","article-title":"Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity","volume":"355","author":"Landew\u00e9","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.ancard.2011.07.008_bib0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03009740500474578","article-title":"Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy","volume":"35","author":"Dahlqvist","year":"2006","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0250","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.ancard.2011.07.008_bib0255","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ancard.2011.07.008_bib0260","first-page":"S276","volume":"58","author":"Mary Chester Wasko","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ancard.2011.07.008_bib0265","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","article-title":"Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis","volume":"56","author":"Munro","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ancard.2011.07.008_bib0270","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kei142","article-title":"\u201cNot only\u2026 but also\u201d: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus","volume":"44","author":"Bruce","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ancard.2011.07.008_bib0275","doi-asserted-by":"crossref","first-page":"S544","DOI":"10.1002\/art.23396","volume":"58","author":"Solomon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ancard.2011.07.008_bib0280","first-page":"83","article-title":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0285","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/ard.2007.086728","article-title":"Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis","volume":"68","author":"Wijbrandts","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ancard.2011.07.008_bib0290","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ancard.2011.07.008_bib0295","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2005.045872","article-title":"Swedish registers to examine drug safety and clinical issues in RA","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ancard.2011.07.008_bib0300","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","article-title":"Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER","volume":"8","author":"Carmona","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ancard.2011.07.008_bib0305","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0310","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.21707","article-title":"Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis","volume":"55","author":"Gonzalez-Juanatey","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0315","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/art.24308","article-title":"Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy","volume":"59","author":"Gonzalez-Juanatey","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ancard.2011.07.008_bib0320","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/s10165-010-0279-5","article-title":"Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions","volume":"20","author":"Nishimoto","year":"2010","journal-title":"Mod Rheumatol"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392811001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392811001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T10:26:17Z","timestamp":1543573577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392811001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0003392811001181"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2011.07.008","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}